AbbVie
Trade AbbVie 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABBV
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions.
ABBV Key Statistics
ABBV News
As the Federal Reserve's recent interest rate cut creates a mixed reaction in U.S. stock markets, with the Dow Jones Industrial Average rising while the Nasdaq...
Abbvie ((ABBV)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powe...
Healthcare On the Move Oruka jumps as lead drug outperforms AbbVie’s Skyrizi in early-stage trial Sep. 17, 2025 8:46 AM ET Oruka Therapeutics, Inc. (ORKA) Stoc...
Analyst ratings
65%
of 31 ratingsMore ABBV News
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...
AbbVie, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Luisa Hector from Berenberg Bank upgraded the rating on the sto...
If you are trying to figure out what to do with your AbbVie (ABBV) shares, the most recent development might catch your eye. The company just settled with gener...
Abbvie ((ABBV)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock po...
The shares of AbbVie (ABBV) climbed nearly 5% on Thursday morning after the American drugmaker reached a settlement with manufacturers producing “generic” or ch...
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...